Women’s History Month: Ernestine Hambrick’s contributions to colorectal cancer surgery

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Ernestine Hambrick

Ernestine Hambrick, the first woman board-certified in colon and rectal surgery, is the recipient of the 2022 American College of Surgeons Dr. Mary Edwards Walker Inspiring Women in Surgery Award. 

ACS President Julie A. Freischlag presented the award, which recognizes a surgeon’s significant contributions to the advancement of women in the field of surgery, to Hambrick earlier this evening during the Convocation ceremony preceding the opening of the ACS Clinical Congress 2022. 

Hambrick’s achievements include pioneering education and advocacy programs that raised public awareness of colorectal cancer and helped expand access to preventive screenings. She is the first colorectal surgeon to be honored with the prestigious award.

Born in the small town of Griffin, Georgia, in 1941, Hambrick spent much of her youth running around the backyard of her family’s home, a modest four-room house with no indoor bathroom. As a young child, she fell and cut her eyelid, requiring stitches to heal the wound. It was that brief encounter with a family physician that left a permanent impression on her.

“On the car ride home, I apparently said to my mother and father: ‘He was a nice man. I’m going to be a doctor, too’,” she said.

Despite her resolute words at a young age, she faced long odds. When she was 6 years old, her father, who worked in the town’s cotton mill, passed away. Left to raise two young children alone, her mother moved the family to Tennessee and then to Maryland, where she pursued a nursing degree.

In high school, Hambrick poured over medical journals that illustrated operations, sparking a lifelong interest in the way surgery can heal patients. She studied pre-medical courses at the University of Maryland, graduating with a Bachelor of Science in 1963, and entered medical school at the University of Illinois College of Medicine in Chicago. 

Though about 20% of her classmates were women—far above the national average at that time—few women pursued careers in surgery. When Hambrick told a school counselor about her plans to become a surgeon, he brushed her ambition aside: “You need to change your goals. Women aren’t made to be surgeons.” Determined to follow her passion, Hambrick would not be dissuaded.

A memorable moment during her obstetrics/gynecology rotation in medical school helped solidify her passion for the field of surgery. A patient on the floor developed a massive, life-threatening hemorrhage in her upper gastrointestinal tract. She witnessed general surgery resident Olga Jonasson respond to the emergency and perform a life-saving operation. “I distinctly remember watching Jonasson and saying to myself, “If she can do it, I can do it,’” Hambrick recalled.

After graduating from medical school, Hambrick was accepted into the general surgery internship and residency training program at Chicago’s Cook County Hospital, becoming its first woman surgical resident in 25 years. At Cook County Hospital, Durand Smith and Herand Abcarian became her close mentors, nurturing her interest in colorectal surgery. She completed residency training in general surgery in 1972 and a year later, became the first woman board certified in colon and rectal surgery by the American Board of Colon and Rectal Surgery.

After completing her training, she joined the medical staff at Cook County Hospital and later established a private practice at Michael Reese Hospital and Medical Center, serving city residents who no longer had to travel out of state to receive colonoscopies. Colleagues remember her ability to perform complex surgical procedures with precision, along with the extraordinary amount of time she dedicated to patient care.

“She was extremely caring. When she went into the room and came out, the patient and the family were sure that she could take care of the problem,” remembered Abcarian, her longtime mentor and colleague. “She would put the plan into play about what she was going to do, and the family would say, ‘She is not only good, but she took time to talk to us.’ This communication between the surgeon, patient, and the family was one area where Dr. Hambrick excelled.”

Early in her career, Hambrick and colleagues noted that polyp removal by colonoscopy could prevent colorectal cancer, but routine screenings with colonoscopy were not yet commonplace. In 1992, the harsh reality of colorectal cancer’s lethality struck a more personal note: her only brother succumbed to the disease at age 55. 

Motivated to increase public awareness of colorectal cancer and screening procedures, she established the STOP Colon/Rectal Cancer Foundation in 1998. The foundation produced impactful national and international campaigns, including a Telly-award-winning video encouraging screenings among Chicago police officers.

“It became clear to me that nobody needed to lose a brother like that. Nobody needed to lose a father or mother,” Hambrick recalled. “We knew how to prevent colon cancer. But that knowledge was new knowledge, and it needed to be disseminated not only through the medical profession, but also in the public domain.”


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available.  

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj, or follow our podcast.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.

Login